Barbeau_2020_Stem.Cell.Res_49_102106

Reference

Title : Generation of a human induced pluripotent stem cell line (iPSC) from peripheral blood mononuclear cells of a patient with a myasthenic syndrome due to mutation in COLQ - Barbeau_2020_Stem.Cell.Res_49_102106
Author(s) : Barbeau S , Desprat R , Eymard B , Martinat C , Lemaitre JM , Legay C
Ref : Stem Cell Res , 49 :102106 , 2020
Abstract :

Congenital myasthenic syndromes (CMS) are a class of inherited disorders affecting the neuromuscular junction, a synapse whose activity is essential for movement. CMS with acetylcholinesterase (AChE) deficiency are caused by mutations in COLQ, a collagen that anchors AChE in the synapse. To study the pathophysiological mechanisms of the disease in human cells, we have generated iPSC from a patient's Peripheral Blood Mononuclear cells (PBMC) by reprogramming these cells using a non-integrative method using Sendai viruses bearing the four Yamanaka factors Oct3/4, Sox2, Klf4, and L-Myc.

PubMedSearch : Barbeau_2020_Stem.Cell.Res_49_102106
PubMedID: 33370874

Related information

Citations formats

Barbeau S, Desprat R, Eymard B, Martinat C, Lemaitre JM, Legay C (2020)
Generation of a human induced pluripotent stem cell line (iPSC) from peripheral blood mononuclear cells of a patient with a myasthenic syndrome due to mutation in COLQ
Stem Cell Res 49 :102106

Barbeau S, Desprat R, Eymard B, Martinat C, Lemaitre JM, Legay C (2020)
Stem Cell Res 49 :102106